Delivery Order SPE2DB22D1103-SPE2DB25FTNL1
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,367.21 firm fixed-price contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award has a performance period ending on May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set-aside. The company holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $5,393.79. The contract is a firm-fixed price delivery order, with a period of performance ending on May 29, 2025. The contract is not set aside and was awarded on May 28, 2025. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,164.42, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and the ultimate completion date...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a potential value of $1,007.95 and a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with a ceiling value of $2,254.24 and a completion date of February 7, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,240.90 firm fixed-price contract is for the delivery of 4565006580 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has a completion date of June 27, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,472.03, is for the delivery of 4562300674 ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, to support military and federal healthcare programs. The contract is a firm fixed-price delivery order, with a period of performance through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The award, valued at $5,586.93, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,598.67, is for the delivery of atovaquone-proguanil 250-100 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $43,764.00 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Atovaquone-Proguanil 250-100 100s pharmaceutical products. This delivery order contract has a firm fixed price pricing type and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award....